Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Agilent Technologies, Inc. provides core bio-analytical and electronic measurement solutions to the communications, electronics, life sciences, and chemical analysis industries. The Company offers electronic and bio-analytical measurement, semiconductor, and board testing.
Website: agilent.com



Growth: Bad revenue growth rate -5.6%, there is slowdown compared to average historical growth rates 7.4%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -1.0%

Profitability: LTM EBITDA margin is positive, +24.4%. On average the margin is decreasing unsteadily. Gross margin is high, +55.1%. In the last quarter the company beat the estimated EPS, +0.8%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.07 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.5%. Free cash flow yield 2.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 35.5% higher than minimum and 23.6% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.9x by EV / Sales multiple , the company can be 54.1% overvalued

Insiders: For the last 3 months insiders sold company shares on $9.2 mln (-0.021% of cap.)

Key Financials (Download financials)

Ticker: A
Share price, USD:  (-1.6%)137.04
year average price 126.07  


year start price 133.12 2023-04-26

min close price 101.17 2023-10-30

max close price 149.31 2024-03-07

current price 137.04 2024-04-24
Common stocks: 296 000 000

Dividend Yield:  0.5%
FCF Yield LTM: 2.4%
EV / LTM EBITDA: 25.6x
EV / EBITDA annualized: 23.5x
Last revenue growth (y/y):  -5.6%
Last growth of EBITDA (y/y):  -9.5%
Historical revenue growth:  7.4%
Historical growth of EBITDA:  12.8%
EV / Sales: 6.2x
Margin (EBITDA LTM / Revenue): 24.4%
Fundamental value created in LTM:
Market Cap ($m): 41 203
Net Debt ($m): 807
EV (Enterprise Value): 42 010
Price to Book: 6.4x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-09Zacks Investment Research

Agilent (A) is Set for Analytica 2024 With Advanced Products

2024-04-05Zacks Investment Research

Agilent (A) to Bolster DCG Segment With Upcoming Solutions

2024-04-02Zacks Investment Research

Agilent (A) Boosts LSAG Segment With Advanced Dilution System

2024-03-29Zacks Investment Research

Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch

2024-03-28Zacks Investment Research

Agilent (A) Up 7.6% Since Last Earnings Report: Can It Continue?

2024-03-25CNBC

Trump New York fraud bond cut to $175 million in appeal from $454 million

2024-03-06Zacks Investment Research

Why Agilent Technologies (A) is a Top Stock for the Long-Term

2024-03-04Seeking Alpha

Agilent Technologies, Inc. (A) Presents at 44th Annual TD Cowen Health Care Conference (Transcript)

2024-02-28Zacks Investment Research

Agilent (A) Q1 Earnings & Revenues Beat Estimates, Dip Y/Y

2024-02-27Investopedia

Agilent Technologies Stock Jumps As Earnings Top Estimates—Key Levels to Watch
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31
symbol A A A A A A
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-05 2023-12-20 2023-08-31 2023-05-26 2023-03-03 2022-12-21
acceptedDate 2024-03-04 18:49:08 2023-12-19 18:52:16 2023-08-30 18:47:03 2023-05-26 17:28:42 2023-03-02 18:52:33 2022-12-20 18:42:30
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4
revenue 1 658M 1 688M 1 672M 1 717M 1 756M 1 849M
costOfRevenue 745M 773M 1 014M 793M 788M 837M
grossProfit 913M 915M 658M 924M 968M 1 012M
grossProfitRatio 0.551 0.542 0.394 0.538 0.551 0.547
researchAndDevelopmentExpenses 120M 114M 118M 126M 123M 119M
generalAndAdministrativeExpenses 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 393M 393M 407M 415M 419M 422M
otherExpenses 23M 17M 10M 6M 0 0
operatingExpenses 513M 507M 525M 541M 542M 541M
costAndExpenses 1 258M 1 280M 1 539M 1 334M 1 330M 1 378M
interestIncome 18M 17M 13M 12M 9M 5M
interestExpense 22M 22M 24M 24M 25M 23M
depreciationAndAmortization 62M 62M 71M 89M 76M 80M
ebitda 462M 504M 227M 472M 502M 551M
ebitdaratio 0.279 0.299 0.136 0.275 0.286 0.298
operatingIncome 400M 408M 133M 383M 426M 471M
operatingIncomeRatio 0.241 0.242 0.080 0.223 0.243 0.255
totalOtherIncomeExpensesNet 3M 17M 10M -6M -16M -16M
incomeBeforeTax 403M 420M 132M 377M 410M 455M
incomeBeforeTaxRatio 0.243 0.249 0.079 0.220 0.233 0.246
incomeTaxExpense 55M -55M 21M 75M 58M 87M
netIncome 348M 475M 111M 302M 352M 368M
netIncomeRatio 0.210 0.281 0.066 0.176 0.200 0.199
eps 1.190 1.630 0.380 1.020 1.190 1.240
epsdiluted 1.180 1.620 0.380 1.020 1.190 1.230
weightedAverageShsOut 293M 292M 295M 296M 296M 296M
weightedAverageShsOutDil 294M 293M 295M 297M 297M 298M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31
symbol A A A A A A
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-05 2023-12-20 2023-08-31 2023-05-26 2023-03-03 2022-12-21
acceptedDate 2024-03-04 18:49:08 2023-12-19 18:52:16 2023-08-30 18:47:03 2023-05-26 17:28:42 2023-03-02 18:52:33 2022-12-20 18:42:30
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4
cashAndCashEquivalents 1 748M 1 590M 1 329M 1 175M 1 250M 1 053M
shortTermInvestments 0 0 0 0 7M 0
cashAndShortTermInvestments 1 748M 1 590M 1 329M 1 175M 1 250M 1 053M
netReceivables 1 295M 1 291M 1 339M 1 401M 1 459M 1 405M
inventory 1 033M 1 031M 1 072M 1 103M 1 111M 1 038M
otherCurrentAssets 262M 274M 290M 270M 258M 282M
totalCurrentAssets 4 338M 4 186M 4 030M 3 949M 4 078M 3 778M
propertyPlantEquipmentNet 1 469M 1 270M 1 211M 1 184M 1 147M 1 100M
goodwill 3 967M 3 960M 3 984M 3 980M 4 793M 4 773M
intangibleAssets 443M 475M 502M 798M 810M 821M
goodwillAndIntangibleAssets 4 410M 4 435M 4 486M 4 778M 4 793M 4 773M
longTermInvestments 172M 164M 190M 186M 188M 195M
taxAssets 0 284M 0 0 0 0
otherNonCurrentAssets 559M 424M 758M 695M 713M 670M
totalNonCurrentAssets 6 610M 6 577M 6 645M 6 843M 6 841M 6 738M
otherAssets 0 0 0 0 0 0
totalAssets 10 948M 10 763M 10 675M 10 792M 10 919M 10 516M
accountPayables 488M 418M 452M 479M 540M 580M
shortTermDebt 46M 46M 55M 0 238M 36M
taxPayables 0 73M 0 0 0 0
deferredRevenue 522M 505M 512M 519M 521M 461M
otherCurrentLiabilities 561M 634M 741M 668M 637M 784M
totalCurrentLiabilities 1 617M 1 603M 1 760M 1 666M 1 936M 1 861M
longTermDebt 2 555M 2 735M 2 734M 2 733M 2 733M 2 733M
deferredRevenueNonCurrent 0 -38M 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 38M 0 0 0 0
otherNonCurrentLiabilities 588M 580M 623M 612M 641M 2 289M
totalNonCurrentLiabilities 3 143M 3 315M 3 357M 3 345M 3 374M 3 366M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 118M 118M 0 0 0 0
totalLiabilities 4 760M 4 918M 5 117M 5 011M 5 310M 5 227M
preferredStock 0 0 0 0 0 0
commonStock 3M 3M 3M 3M 3M 3M
retainedEarnings 1 061M 782M 444M 700M 541M 324M
accumulatedOtherComprehensiveIncomeLoss -316M -327M -271M -282M -280M -363M
othertotalStockholdersEquity 5 440M 5 387M 5 382M 5 360M 5 345M 5 325M
totalStockholdersEquity 6 188M 5 845M 5 558M 5 781M 5 609M 5 289M
totalEquity 6 188M 5 845M 5 558M 5 781M 5 609M 5 289M
totalLiabilitiesAndStockholdersEquity 10 948M 10 763M 10 675M 10 792M 10 919M 10 516M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 10 948M 10 763M 10 675M 10 792M 10 919M 10 516M
totalInvestments 172M 164M 190M 186M 195M 195M
totalDebt 2 719M 2 735M 2 789M 2 733M 2 971M 2 769M
netDebt 971M 1 145M 1 460M 1 558M 1 721M 1 716M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31
symbol A A A A A A
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-05 2023-12-20 2023-08-31 2023-05-26 2023-03-03 2022-12-21
acceptedDate 2024-03-04 18:49:08 2023-12-19 18:52:16 2023-08-30 18:47:03 2023-05-26 17:28:42 2023-03-02 18:52:33 2022-12-20 18:42:30
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4
netIncome 348M 475M 111M 302M 352M 368M
depreciationAndAmortization 62M 62M 71M 71M 67M 73M
deferredIncomeTax -105M 13M -68M -5M 4M -17M
stockBasedCompensation 44M 14M 29M 24M 44M 26M
changeInWorkingCapital 21M -48M 129M -7M -190M -43M
accountsReceivables 10M 19M 64M 54M -5M -88M
inventory -9M 20M 18M -2M -69M -42M
accountsPayables 84M -54M -16M -74M -27M 11M
otherWorkingCapital -64M -33M 63M 15M -89M 76M
otherNonCashItems 115M 0 290M 13M 19M 41M
netCashProvidedByOperatingActivities 485M 516M 562M 398M 296M 448M
investmentsInPropertyPlantAndEquipment -90M -84M -81M -57M -76M -70M
acquisitionsNet 0 50M 0 -21M -30M -34M
purchasesOfInvestments 0 -5M -2M 0 -1 000 000 -3M
salesMaturitiesOfInvestments 0 0 0 1 000 000 4M 6M
otherInvestingActivites -5M -1 000 000 -6M 0 -1 000 000 -9M
netCashUsedForInvestingActivites -95M -40M -89M -77M -104M -110M
debtRepayment -180M -55M -1 622M -1 298M -324M -500M
commonStockIssued 34M 2M -1 537M 0 35M 58M
commonStockRepurchased 0 -80M -335M -85M -75M -135M
dividendsPaid -69M -66M -66M -66M -67M -62M
otherFinancingActivites -25M -2M 3 238M 1 059M 414M 298M
netCashUsedProvidedByFinancingActivities -240M -201M -322M -390M -17M -341M
effectOfForexChangesOnCash 7M -14M 3M -6M 22M -14M
netChangeInCash 158M 261M 154M -75M 197M -17M
cashAtEndOfPeriod 1 748M 1 593M 1 332M 1 178M 1 253M 1 056M
cashAtBeginningOfPeriod 1 590M 1 332M 1 178M 1 253M 1 056M 1 073M
operatingCashFlow 485M 516M 562M 398M 296M 448M
capitalExpenditure -90M -84M -81M -57M -76M -70M
freeCashFlow 395M 432M 481M 341M 220M 378M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-27 ET (fiscal 2024 q1)
2023 q3
2023-11-20 ET (fiscal 2023 q4)
2023 q2
2023-08-15 ET (fiscal 2023 q3)
2023 q1
2023-05-23 ET (fiscal 2023 q2)
2022 q4
2023-02-28 ET (fiscal 2023 q1)
2022 q3
2022-11-21 ET (fiscal 2022 q4)
2022 q2
2022-08-16 ET (fiscal 2022 q3)
2022 q1
2022-05-24 ET (fiscal 2022 q2)
2021 q4
2022-02-22 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-27 21:05 ET
Agilent Reports First-Quarter Fiscal Year 2024 Financial Results
2024-02-21 21:20 ET
Agilent Announces Cash Dividend of 23.6 Cents per Share
2024-02-21 21:12 ET
Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect
2024-02-13 15:11 ET
Agilent Ranked Among Top 50 Most Just Companies in America
2024-02-08 13:00 ET
Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products
2024-02-07 16:20 ET
Agilent to Participate in TD Cowen Health Care Conference
2024-01-30 13:00 ET
Agilent Announces Collaboration with Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology
2024-01-25 17:29 ET
Agilent to Announce First-Quarter Fiscal Year 2024 Financial Results Feb. 27
2024-01-16 13:00 ET
Agilent Announces New ProteoAnalyzer System
2024-01-05 15:29 ET
Agilent Named to Dow Jones Sustainability Indices for Ninth Consecutive Year
2023-12-20 13:58 ET
Agilent Makes Strategic Updates to Organizational Structure
2023-12-18 15:01 ET
Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-14 20:17 ET
Agilent Again Named “Global Lighthouse” by World Economic Forum for Manufacturing Innovations
2023-12-07 13:00 ET
Agilent Resolve Raman Receives Multiple Recognitions for HazMat and CBRN Excellence
2023-12-04 13:00 ET
Agilent BioTek Cytation C10 Confocal Imaging Reader Enhanced with Innovative Water Immersion Technology
2023-11-20 21:05 ET
Agilent Reports Fourth-Quarter Fiscal Year 2023 Financial Results
2023-11-17 16:59 ET
Agilent to Present at the Evercore ISI HealthCONx Conference
2023-11-15 21:02 ET
Agilent Increases Cash Dividend to 23.6 Cents per Share
2023-11-14 13:00 ET
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
2023-11-13 13:00 ET
Agilent Announces Thought Leader Award to Professor Jennifer Field
2023-10-23 14:28 ET
Agilent to Announce Fourth-Quarter Fiscal Year 2023 Financial Results Nov. 20
2023-10-19 13:15 ET
Agilent’s Net-Zero Emissions Targets Approved by the Science Based Targets Initiative
2023-09-20 19:06 ET
Agilent Announces Cash Dividend of 22.5 Cents Per Share
2023-09-05 11:20 ET
Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group
2023-08-24 12:00 ET
Agilent Receives European IVDR Certification for Companion Diagnostic Assay
2023-08-15 20:05 ET
Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results
2023-08-09 12:00 ET
Agilent 2023 Early Career Professor Award Presented to Ajit Divakaruni
2023-08-03 12:00 ET
Agilent Announces Thought Leader Award to Peter Neubauer
2023-07-31 13:00 ET
Agilent’s 2022 ESG Report Shows Progress Helping Customers Reach Their Sustainability Goals
2023-07-19 16:00 ET
Agilent to Announce Third-Quarter Fiscal Year 2023 Financial Results Aug. 15
2023-07-10 14:52 ET
Agilent Achieves Great Place to Work® Certification
2023-07-10 12:01 ET
Agilent Announces Gen6 Software for BioTek Line of Microplate Readers
2023-07-03 12:00 ET
Agilent Innovation Again Recognized with Multiple Scientists' Choice Awards
2023-06-12 12:00 ET
Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference
2023-06-08 12:00 ET
Agilent Announces BioTek 406 FX Washer Dispenser for Technology-Driven Workflow Efficiency
2023-06-08 12:00 ET
Agilent Independent Global Lab Sustainability Survey Sheds Light on Progress Towards Greener Labs
2023-06-06 12:00 ET
Agilent Announces Enhanced xCELLigence RTCA Software Pro to Support Regulatory Compliance Requirements
2023-06-05 12:00 ET
Agilent Announces Full Workflow for US EPA Method 1633 for Targeted PFAS Analysis
2023-06-05 12:00 ET
Agilent Announces Inspirational LC/TQ and LC/Q-TOF Mass Spectrometry Solutions at ASMS 2023
2023-06-02 12:00 ET
Agilent Intelligent Mass Spectrometry Solutions to Inspire at ASMS 2023
2023-05-23 20:05 ET
Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results
2023-05-22 22:00 ET
Agilent to Present at Jefferies and Goldman Sachs Healthcare Conferences
2023-05-19 01:25 ET
Agilent to Appeal Patent Office Decision on CRISPR gRNA Patents
2023-05-17 19:57 ET
Agilent Announces Cash Dividend of 22.5 Cents Per Share
2023-05-16 18:47 ET
Agilent Wins SEAL Award for Innovative Products that Help Customers Achieve Their Sustainability Goals
2023-05-04 12:00 ET
Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye
2023-04-26 17:05 ET
Agilent to Announce Second-Quarter Fiscal Year 2023 Financial Results May 23
2023-04-14 12:00 ET
Agilent Showcases Comprehensive Cancer Portfolio Solutions at AACR 2023
2023-04-13 12:29 ET
Agilent Announces NGS Assay for Comprehensive Genomic Profiling (CGP) for Advancing Precision Oncology
2023-04-12 12:00 ET
Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications
2023-04-03 12:00 ET
Agilent Announces High-Performance Cary 3500 Flexible UV-Vis System
2023-04-03 07:00 ET
Agilent Announces Thought Leader Award to Dr. Chenli Liu
2023-03-24 00:00 ET
Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research Institute Scientist, Kathryn Wolhuter
2023-03-20 18:00 ET
Agilent Announced as Instrument Business Outlook 2022 Company of the Year
2023-03-14 15:00 ET
Market Disruptor Axion BioSystems Rejects Agilent Technologies, Inc. Allegations
2023-03-10 13:01 ET
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
2023-03-10 13:00 ET
Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu
2023-03-09 21:05 ET
Agilent Again Named One of Barron’s 100 Most Sustainable Companies
2023-03-09 19:10 ET
Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development
2023-03-08 13:00 ET
Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine
2023-03-06 18:30 ET
Agilent to Present at Barclays Global Healthcare Conference
2023-02-28 21:05 ET
Agilent Reports First-Quarter Fiscal Year 2023 Financial Results
2023-02-27 13:00 ET
Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler
2023-02-24 13:00 ET
Agilent Announces Cell Analysis Workflow Automation for Immuno-Oncology, Virology, and Vaccine Development Markets
2023-02-22 21:10 ET
Agilent Announces Cash Dividend of 22.5 Cents Per Share
2023-02-22 13:00 ET
Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions
2023-02-16 22:43 ET
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick
2023-02-09 13:00 ET
Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance
2023-01-30 18:29 ET
Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28
2023-01-18 18:23 ET
Agilent Included in Just Capital’s 2023 List of Most Just Companies
2023-01-09 21:30 ET
Agilent Authorizes $2 Billion Share Repurchase Program
2023-01-09 13:45 ET
Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
2023-01-04 13:45 ET
Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
2022-12-16 18:30 ET
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
2022-12-13 01:50 ET
Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer
2022-12-07 18:44 ET
Agilent Again Named to Newsweek’s List of America’s Most Responsible Companies
2022-12-05 13:00 ET
Agilent Opens Customer Experience Center Highlighting Genomics and Diagnostics Solutions
2022-11-30 13:00 ET
Agilent Attains ‘Angel’ Level Sponsorship with My Green Lab
2022-11-29 13:00 ET
Agilent Deploys Next Generation Explosive Detection System at London Heathrow Airport
2022-11-21 21:05 ET
Agilent Reports Fourth-Quarter and Fiscal Year 2022 Financial Results
2022-11-16 21:05 ET
Agilent Announces Cash Dividend of 22.5 Cents Per Share
2022-11-16 00:00 ET
Agilent to Present at the Evercore ISI HealthCONx Conference
2022-11-14 13:00 ET
Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0
2022-11-07 13:00 ET
Agilent Joins the How2Recycle Program
2022-11-01 18:30 ET
Agilent to Announce Fourth-Quarter Fiscal Year 2022 Financial Results Nov. 21
2022-10-12 12:00 ET
Agilent Opens Center of Excellence for Dissolution Products
2022-10-11 06:00 ET
World Economic Forum Recognizes Agilent Facility in Singapore as a Leader in Advanced Manufacturing
2022-10-03 12:00 ET
Agilent Announces Enhanced 8700 LDIR Chemical Imaging System for Microplastics Analysis
2022-09-29 17:01 ET
Agilent Launches Partnership with Delaware State University to Advance Diversity in Science, Technology, Engineering and Math (STEM) Fields
2022-09-21 20:05 ET
Agilent Announces Cash Dividend of 21 Cents Per Share
2022-09-14 17:48 ET
Agilent Earns Great Place to Work® Certification in 20 Countries and Regions
2022-09-12 12:00 ET
Agilent Announces Thought Leader Award to Professor Christoph Herwig
2022-09-08 16:32 ET
Fortune Ranks Agilent Among Top Workplaces in Health Care
2022-09-07 19:25 ET
Agilent Receives Award for Sustainability Leadership
2022-09-01 12:00 ET
Agilent Collaborates with METTLER TOLEDO to Reduce Errors in Sample Preparation Workflows for Better Chromatographic Results
2022-08-16 20:05 ET
Agilent Reports Third-Quarter Fiscal Year 2022 Financial Results
2022-08-02 12:30 ET
Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis
2022-08-02 12:07 ET
Agilent Announces Thought Leader Award to Gerhardt Attard at University College London (UCL)
2022-07-27 12:06 ET
Agilent 2022 Early Career Professor Award Presented to Stefanos Nikolaidis
2022-07-25 13:00 ET
Agilent ESG Report Highlights Plans and Progress to Ensure Future Sustainable Growth
2022-07-19 17:09 ET
Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award
2022-07-19 15:00 ET
Agilent to Announce Third-Quarter Fiscal Year 2022 Financial Results August 16
2022-07-11 12:10 ET
Halo Labs Completes $6M Series C Growth Financing
2022-07-05 12:00 ET
Teva Uses the Agilent TRS100 to Achieve Regulatory Milestone for Content Uniformity Testing with the FDA
2022-06-21 12:00 ET
Agilent Laboratory Achieves Green Lab Certification
2022-06-16 12:00 ET
Agilent Showcases ‘Consistent, Greener, Smarter’ Approach at Analytica 2022
2022-06-15 12:00 ET
Agilent Wins Multiple 2022 Scientists' Choice Awards at ASMS
2022-06-07 14:35 ET
Agilent Leverages NVIDIA and AWS Technology to Improve Analysis Speeds of Genomics Bioinformatics Pipelines
2022-06-06 12:00 ET
Agilent Announces New Oligonucleotide Analysis Software for Biopharma Research
2022-06-06 12:00 ET
Agilent Announces New Revolutionary Quadrupole Mass Spectrometers at ASMS 2022
2022-06-01 20:30 ET
Agilent to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
2022-06-01 12:00 ET
Agilent Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union
2022-05-27 12:00 ET
Agilent Announces Collaboration with APC on Real-Time Process Monitoring
2022-05-24 20:05 ET
Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results
2022-05-18 20:05 ET
Agilent Announces Cash Dividend of 21 Cents per Share
2022-05-10 19:50 ET
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
2022-04-26 15:00 ET
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
2022-04-19 12:00 ET
Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
2022-04-08 12:00 ET
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
2022-04-05 12:25 ET
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
2022-04-05 12:15 ET
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
2022-04-04 12:00 ET
Agilent Joins AMBIC to Advance Biomanufacturing
2022-03-15 11:10 ET
Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational Applications
2022-03-10 13:00 ET
Agilent Announces the 2022 Darlene Solomon Award Presented to Grenoble Alpes University Hospital Scientist Dr. Federica Fiorini
2022-02-24 18:52 ET
Agilent to Participate at Cowen and Barclays Health Care Conferences
2022-02-24 13:00 ET
Agilent and University of Vermont Announce the Agilent Laboratory for Chemical Analysis (ALCA)
2022-02-23 13:00 ET
Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening
2022-02-22 21:05 ET
Agilent Reports First-Quarter Fiscal Year 2022 Financial Results
2022-02-17 14:00 ET
Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity
2022-02-15 21:05 ET
Agilent Announces Cash Dividend of 21 Cents per Share
2022-02-04 13:00 ET
Agilent Highlights Integrated Automation Solutions at SLAS 2022
2022-01-27 01:00 ET
Agilent and A*STAR’s SIFBI Sign Research Collaboration Agreement to Advance Singapore Agri-Food Industry
2022-01-24 13:30 ET
Agilent Announces the Innovative Seahorse XF Pro Analyzer
2022-01-13 21:05 ET
Agilent to Webcast First-Quarter Fiscal Year 2022 Financial Results Presentation
2022-01-10 13:18 ET
Agilent Presents Thought Leader Award to Professor Jason Kovacic
2021-12-16 14:41 ET
Nicoya Extends Series A Financing With Additional $20m to Meet Demand of Rapidly Growing Proteomics Industry
2021-12-14 16:00 ET
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
2021-12-06 13:00 ET
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
2021-11-23 20:00 ET
Agilent to Present at Evercore ISI Virtual Healthcare Conference
2021-11-22 21:05 ET
Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
2021-11-18 21:05 ET
Dr. Otis Brawley Named to Agilent Board of Directors
2021-11-17 21:05 ET
Agilent Increases Cash Dividend to 21 Cents Per Share
2021-11-02 18:00 ET
Agilent Names John Palma to Lead Global Medical Affairs Organization
2021-11-01 12:06 ET
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
2021-10-28 20:47 ET
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
2021-10-28 20:05 ET
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
2021-10-27 12:00 ET
Agilent Commits to Net-Zero Greenhouse Gas Emissions by 2050
2021-10-26 12:05 ET
Agilent Announced as My Green Lab's First 'Transformative Level' Sponsor and First Sponsor of the My Green Lab Certification Program
2021-10-21 12:31 ET
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
2021-10-13 20:16 ET
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
2021-09-28 12:00 ET
Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)
2021-09-23 20:05 ET
Dr. Mikael Dolsten Named to Agilent Board of Directors
2021-09-22 20:05 ET
Agilent Announces Cash Dividend of 19.4 Cents per Share
2021-09-07 12:00 ET
Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute
2021-09-02 12:00 ET
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
2021-09-01 15:00 ET
Agilent to Present at Wells Fargo Virtual Healthcare Conference
2021-08-23 15:00 ET
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer
2021-08-19 12:00 ET
Researchers Develop COVID-19 Severity Screening Method Based on the Agilent Cary 630 FTIR Spectrometer
2021-08-17 20:05 ET
Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results
2021-08-04 15:00 ET
Agilent Earns 2021 Great Place to Work Certification in the U.S.
2021-08-03 12:20 ET
Agilent Announces Target Enrichment Manufacturing Facility in China
2021-07-28 12:00 ET
Agilent Early Career Professor Award Presented to Jason H. Yang
2021-07-27 12:00 ET
Clinical Utility of ALK Fusion Detection by Liquid Biopsy
2021-07-22 15:01 ET
Agilent Technologies Celebrates More Than 20 Years of Sustainable Progress
2021-07-22 15:00 ET
Agilent Technologies Celebrates More than 20 Years of Sustainable Progress
2021-07-21 12:00 ET
Agilent to Webcast Third-Quarter Fiscal Year 2021 Financial Results Presentation
2021-07-20 16:34 ET
Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
2021-07-20 12:30 ET
Agilent Announces Optimized and Verified Method for Testing Over 100 PFAS Compounds
2021-07-13 13:00 ET
MOBILion Systems Inc. Announces $60 Million Series C Financing Round Led by D1
2021-06-28 12:00 ET
Resolution Bioscience (a part of Agilent) Investigated Acquired Resistance to KRAS G12C Inhibition
2021-06-22 07:00 ET
Agilent Completes the InfinityLab Bio LC Portfolio
2021-06-14 12:00 ET
Agilent Presents Thought Leader Award to Dr. Stéphane Bayen
2021-06-04 12:00 ET
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
2021-06-02 12:00 ET
Agilent Announces New SureSelect Human All Exon V8
2021-06-01 12:00 ET
Agilent Presents Thought Leader Award to Professor Chris Elliott
2021-05-25 20:05 ET
Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results
2021-05-20 17:12 ET
Agilent to Present at Jefferies Virtual Healthcare Conference
2021-05-19 20:05 ET
Agilent Announces Cash Dividend of 19.4 Cents per Share
2021-05-03 19:00 ET
Agilent to Webcast Second-Quarter Fiscal Year 2021 Financial Results Presentation
2021-04-22 12:02 ET
Agilent LC/MS Instruments Receive ACT Labels from My Green Lab
2021-04-20 16:19 ET
Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year
2021-04-15 20:05 ET
Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology
2021-04-14 00:00 ET
Agilent Named One of Singapore’s Best Employers
2021-03-31 10:00 ET
 Oxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D use
2021-03-30 12:00 ET
Agilent Awards Octagon Therapeutics with a Golden Ticket at LabCentral
2021-03-17 20:05 ET
Agilent Announces Cash Dividend of 19.4 Cents per Share
2021-03-15 12:00 ET
Agilent Announces the 8697 Headspace Sampler with Integrated Intelligence
2021-03-09 17:07 ET
Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
2021-03-09 13:00 ET
Agilent Completes CE-IVD Registration of qRT-PCR In Vitro Diagnostic Kit for SARS-CoV-2 RNA Detection
2021-03-03 22:56 ET
Agilent Technologies Announces Pricing of $850 Million of Senior Notes
2021-03-03 13:40 ET
Agilent Technologies Announces Proposed Offering of Senior Notes
2021-03-02 13:00 ET
Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics
2021-03-02 07:00 ET
Agilent Announces Darlene Solomon Award Presented to University of Geneva Scientist Noemi Jiménez-Rojo
2021-02-22 18:46 ET
Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
2021-02-18 22:36 ET
Agilent Ranks No. 2 on Barron’s List of America’s Most Sustainable Companies
2021-02-18 13:00 ET
Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies
2021-02-17 13:00 ET
Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis
2021-02-16 21:05 ET
Agilent Reports First-Quarter Fiscal Year 2021 Financial Results
2021-02-08 19:00 ET
Agilent to Present at Upcoming Investor Events; Provides Webcast Details for Annual Shareholder Meeting
2021-02-01 16:00 ET
Agilent Wins Trade Secret and Patent Infringement Litigation
2021-01-26 16:00 ET
Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation
2021-01-25 13:00 ET
Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines
2021-01-15 18:37 ET
Agilent Names Allison Ballmer Senior Vice President of Strategy and Corporate Development
2020-12-23 03:00 ET
Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan
2020-12-16 16:00 ET
Agilent Announces Webcasts for Investment Community
2020-12-14 13:00 ET
Agilent Receives Multiple Innovation Awards
2020-12-11 15:00 ET
Agilent Releases 2019 Corporate Social Responsibility Report
2020-12-07 05:30 ET
Agilent Presents Thought Leader Award to IIT Delhi Scientist Professor Anurag Rathore
2020-12-03 13:00 ET
Agilent Announces Alissa Interpret Selected by North West Genomic Laboratory Hub for Clinical Genomic Analysis
2020-12-02 13:00 ET
Agilent Announces New, Innovative 7850 ICP-MS System
2020-11-30 13:00 ET
Agilent Announces Launch of Global Biomarker Pathologist Training Program
2020-11-23 21:05 ET
Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance
2020-11-23 13:00 ET
Agilent Launches New NanoDis System for Nanoparticle Dissolution Testing
2020-11-18 21:05 ET
Agilent Increases Cash Dividend to 19.4 Cents Per Share
2020-11-17 13:32 ET
Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
2020-11-14 01:26 ET
Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer
2020-11-04 13:00 ET
Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ
2020-10-29 19:00 ET
Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting
2020-10-19 11:38 ET
Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020
2020-10-15 12:00 ET
Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 Award
2020-10-14 12:00 ET
Agilent Early Career Professor Award Presented to Carl DeSelm
2020-10-08 14:32 ET
Agilent Announces the Availability of Objective Decision Support for Pathologists Reviewing Breast Cancer Cases
2020-09-17 12:00 ET
Agilent Expands Line of Innovative Flow Cytometers with the NovoCyte Penteon
2020-09-16 20:05 ET
Agilent Announces Cash Dividend of 18 Cents Per Share
2020-09-03 19:30 ET
Agilent Announces Webcast for Investment Community
2020-09-01 12:00 ET
Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-Seq
2020-08-27 12:00 ET
Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model
2020-08-18 20:05 ET
Agilent Reports Third-Quarter Fiscal Year 2020 Financial Results
2020-08-18 12:00 ET
Agilent to Expand State-of-the-Art Manufacturing Capacity for Nucleic Acid-Based Therapeutics
2020-08-17 13:00 ET
MOBILion Closes $35M Series B Financing Round
2020-07-27 15:00 ET
Agilent to Webcast Third-Quarter Fiscal Year 2020 Financial Results Conference Call
2020-06-01 20:30 ET
Agilent Technologies Announces Pricing of $500 Million of Senior Notes
2020-06-01 12:48 ET
Agilent Technologies Announces Proposed Offering of Senior Notes
2020-06-01 12:00 ET
Agilent Announces New Mass Spectrometry Products at ASMS 2020 Reboot
2020-05-27 15:00 ET
Agilent to Present at Jefferies Virtual Healthcare Conference
2020-05-21 20:05 ET
Agilent Reports Second-Quarter Fiscal Year 2020 Financial Results
2020-05-20 20:05 ET
Agilent Announces Cash Dividend of 18 Cents Per Share
2020-05-18 12:00 ET
Agilent PD-L1 Assay Receives FDA Approval for Use as a Companion Diagnostic
2020-05-12 12:00 ET
Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral
2020-04-23 12:00 ET
Agilent Receives FDA Approval for PD-L1 Companion Diagnostic on Dako Omnis
2020-04-22 12:00 ET
Agilent Signs Sponsorship Agreement with My Green Lab
2020-04-14 12:00 ET
Agilent Technologies Provides Update on COVID-19 Impact; Sets Second-Quarter Earnings Call for May 21
2020-03-31 12:00 ET
Agilent Introduces New Handheld Raw Material ID System for Pharmaceutical Manufacturers
2020-03-30 17:00 ET
Agilent Technologies to Change Location of Annual Meeting
2020-03-30 12:00 ET
Agilent Announces New Class 1 Triple Quadrupole LC/MS System
2020-03-18 20:05 ET
Agilent Technologies Announces Cash Dividend of 18 Cents Per Share
2020-03-17 20:15 ET
Agilent Technologies to Adjourn Annual Meeting Until April 17, 2020
2020-03-16 12:00 ET
Agilent Introduces CrossLab Connect Services for Lab-wide Asset Monitoring
2020-03-12 12:00 ET
Agilent Receives Two Scientists’ Choice Awards
2020-03-03 13:00 ET
Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research
2020-03-02 16:00 ET
Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions
2020-02-28 13:00 ET
Agilent Technologies Announces Webcasts for Investment Community
2020-02-18 21:05 ET
Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results
2020-02-06 22:17 ET
Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation
2020-01-30 03:00 ET
Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics
2020-01-28 21:30 ET
Agilent Technologies to Webcast First Quarter Fiscal Year 2020 Financial Results Conference Call
2020-01-27 19:00 ET
Agilent Introduces New Cutting-Edge SureSelect DNA Kit
2020-01-23 13:00 ET
Agilent Announces CrossLab Group Leadership Transition
2020-01-22 13:00 ET
Agilent Wins Multiple Innovation Awards
2020-01-16 13:00 ET
Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema
2020-01-02 13:00 ET
Agilent Expands Cross-Vendor CDS Instrument Control
2019-12-30 13:00 ET
Agilent Compliance Services Voted No. 1 in Global Survey
2019-12-19 21:00 ET
 Agilent Technologies to Present at J.P. Morgan Healthcare Conference
2019-12-06 16:00 ET
Agilent Ranked Among Top Four Best Workplaces in Greater China and Receives Certification as a Best Workplace for Women in Greater China
2019-11-26 13:00 ET
Agilent Receives Multiple Life Science Industry Awards for Innovation
2019-11-25 21:05 ET
Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results
2019-11-22 13:43 ET
Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC)
2019-11-21 13:00 ET
Agilent Announces Applications Open for LabCentral Golden Ticket
2019-11-20 21:05 ET
Agilent Technologies Increases Cash Dividend to 18 Cents Per Share
2019-11-19 13:00 ET
Agilent Announces New ICP-OES Systems with Innovative Instrument Intelligence
2019-11-06 17:00 ET
Agilent Named One of Top 10 Best Workplaces in Singapore
2019-11-04 16:00 ET
CORRECTING and REPLACING Agilent Technologies to Host Conference Call to Review Fourth Quarter Fiscal Year 2019 Financial Results; Announces Schedule for Upcoming Webcasts
2019-04-17 00:04 ET
Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC
2019-04-16 12:00 ET
ACEA Biosciences – A Part of Agilent Launches the xCELLigence RTCA ePacer to improve the Quality and Functionality of hiPSC-Cardiomyocytes for Drug Discovery, Safety Pharmacology, and Cardiac Disease Research
2019-04-16 11:00 ET
Agilent Technologies to Host Webcast of Second-Quarter Fiscal Year 2019 Financial Results Conference Call
2019-03-12 10:00 ET
Agilent Receives Prestigious Gartner Inc. Power of the Profession Award 2019 for Talent Payback of the Year
2019-03-06 12:00 ET
Agilent and Imperial College London Strengthen Partnership
2019-02-28 16:00 ET
Agilent Announces New Library Preparation System for Next Generation Sequencing

SEC forms

Show financial reports only

SEC form 10
2024-03-05 00:00 ET
Agilent Technologies published news for 2023 q4
SEC form 8
2024-02-27 16:06 ET
Agilent Technologies published news for 2023 q4
SEC form 8
2024-02-27 16:06 ET
Agilent Technologies reported for 2023 q4
SEC form 10
2023-12-20 00:00 ET
Agilent Technologies published news for 2023 q3
SEC form 8
2023-11-20 16:06 ET
Agilent Technologies reported for 2023 q3
SEC form 10
2023-08-31 00:00 ET
Agilent Technologies published news for 2023 q2
SEC form 6
2023-08-15 16:06 ET
Agilent Technologies reported for 2023 q2
SEC form 8
2023-08-15 00:00 ET
Agilent Technologies published news for 2023 q2
SEC form 10
2023-05-26 00:00 ET
Agilent Technologies published news for 2023 q1
SEC form 6
2023-05-23 16:07 ET
Agilent Technologies reported for 2023 q1
SEC form 8
2023-05-23 00:00 ET
Agilent Technologies published news for 2023 q1
SEC form 6
2023-05-22 16:05 ET
Agilent Technologies published news for 2023 q1
SEC form 10
2023-03-03 00:00 ET
Agilent Technologies reported for 2022 q4
SEC form 8
2023-02-28 00:00 ET
Agilent Technologies reported for 2022 q4
SEC form 10
2022-12-21 00:00 ET
Agilent Technologies reported for 2022 q3
SEC form 8
2022-11-21 00:00 ET
Agilent Technologies reported for 2022 q3
SEC form 10
2022-09-01 00:00 ET
Agilent Technologies reported for 2022 q2
SEC form 8
2022-08-16 00:00 ET
Agilent Technologies reported for 2022 q2
SEC form 10
2022-05-31 00:00 ET
Agilent Technologies reported for 2022 q1
SEC form 8
2022-05-24 00:00 ET
Agilent Technologies reported for 2022 q1
SEC form 10
2022-03-03 00:00 ET
Agilent Technologies published news for 2021 q4
SEC form 8
2022-02-22 00:00 ET
Agilent Technologies published news for 2021 q4
SEC form 10
2021-12-17 00:00 ET
Agilent Technologies published news for 2021 q3
SEC form 8
2021-11-22 00:00 ET
Agilent Technologies published news for 2021 q3
SEC form 10
2021-09-01 00:00 ET
Agilent Technologies published news for 2021 q2
SEC form 8
2021-08-17 00:00 ET
Agilent Technologies published news for 2021 q2
SEC form 10
2021-06-01 00:00 ET
Agilent Technologies published news for 2021 q1
SEC form 8
2021-05-25 00:00 ET
Agilent Technologies published news for 2021 q1